![John Gay](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Gay
Keine laufenden Positionen mehr
Vermögen: 807 811 $ am 31.05.2026
Profil
John M.
Gay is Chief Financial Officer, Secretary & Treasurer at Pelthos Therapeutics, Inc. since 2026.
Former positions include Director-SEC Reporting at Valassis Digital Corp.
and Maxpoint, Inc. from 2014 to 2018; Chief Financial & Accounting Officer & Secretary at NVN Liquidation, Inc. in 2023; Controller at Furiex Pharmaceuticals, Inc. from 2010 to 2014; Audit Senior Manager at Deloitte & Touche LLP and Arthur Andersen LLP from 2000 to 2010; and Chief Financial Officer at LNHC, Inc. Education includes undergraduate and graduate degrees from The University of North Carolina at Chapel Hill.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
0,88 % | 10.04.2026 | 30 518 ( 0,88 % ) | 807 811 $ | 31.05.2026 |
Aktive Positionen von John Gay
| Unternehmen | Position | Beginn |
|---|
Ehemalige bekannte Positionen von John Gay
| Unternehmen | Position | Ende |
|---|---|---|
| NVN LIQUIDATION, INC. | Finanzdirektor/CFO | 26.09.2023 |
| MAXPOINT INTERACTIVE INC | Corporate Officer/Principal | 01.04.2018 |
Maxpoint, Inc.
 Maxpoint, Inc. Maxpoint, Inc. is a company based in Wylie. | Corporate Officer/Principal | 01.04.2018 |
| FURIEX PHARMACEUTICALS INC | Comptroller/Controller/Auditor | 01.05.2014 |
Ausbildung von John Gay
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
98
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
NVN Liquidation, Inc.
 NVN Liquidation, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops treatment for nitric oxide’s immunomodulatory & anti microbial mechanisms | Health Technology |
Furiex Pharmaceuticals, Inc.
 Furiex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a drug development collaboration company | Health Technology |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services | Commercial Services |
Arthur Andersen LLP
 Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
The University of North Carolina at Chapel Hill
 The University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Valassis Digital Corp.
 Valassis Digital Corp. Advertising/Marketing ServicesCommercial Services Provides digital advertising and marketing automation software solutions | Commercial Services |
Maxpoint, Inc.
Maxpoint, Inc. Maxpoint, Inc. is a company based in Wylie. |
